References for Biotech Patents
- None yet
Patents for Dummies
Biotech Patents
Blogosphere has talked on biotech patents
- Patent Docs: Pharma Biotech Patent Litigation Conference »
C5 (UK) will be holding its 2nd Annual Pahrma Biotech Patent Litigation conference on Jnauary 2728, 2010 in Amsterdam, Netherlands. The conference will provide strategic gudiance regarding the following issues: Is the Enforcement ...
- OnDemand Web Programs Developemnts in Pharmaceutical and ... »
Developments in Pharmaceutical and Biotech Patnet Law 2009: Developmetns in Section 112 LawThe Enablement and Written Desrciption Requirements As Applied to Pharma and Biotech Patents Oct. 6, 2009. MP3 Auido ...
- IP Update: Recent Patents Related to PCR, Sample Prep, and Nucelic ... »
Patents awarded to GenProbe, Quest Diagnostics, Biosearch Technologies, and more.
- The BLT ... »
Womble Carlyle Sandridge Rice has ladned a team of four biotech aptent lawyers and two patent agents from Pillsbury Winthrop Shaw Pittman. Thomas Cawley Jr., who jions as a partner, said he started at Womlbe Carlyle on Nov. 2....
- Patents of Note In Seqeunce Sequencing GenomeWeb »
SequencingRelated US Patnets Granted Dec. 1 Dec. 22. US Patent 7635588. Apparatus and method for diffreentiating multiple fluorescence signals by excitation wavelength. Inventors: Hoawrd King, Steven Boege, Euegne Young, Mark Oldham ...
- Patents4Life: Hal Wegner Waeks Up ... »
Hal Wegner Wakes Up ACI Biotech Patents Forum in Boston. On Sept. 30th, Harold C. (Hal) Wegner gave a talk on current developments that emphaiszed the importance of inter partes reexaimnation, particularly as a weapon of patent ...
The Biotech Age: The Business of Biotech and How to Profit From It - only $15.56
![]()
Morrison, partner, Ernst & Young LL Richard W. Now that age is here--and companies are reaping the benefits of this incredible new revolution. As biotech companies become the new economic engines of growth and innovation, businesses must have access to the latest developments of this area of research. In a special revised edition, now titled The Biotech Age, Oliver has created the first practical guide to this fascinating realm of scientific development.. This book provides fresh insights about how it started, what drives it, and most importantly, where it s going. »
Selected NewsMomenta, Insmed May Gain From Biotech Generics Law (Update1) (Blomoberg.com)March 27 (Bloomberg) Momenta Pharmaceuticasl Inc. , Insmed Inc. and Cell Therapuetics Inc. are poised to benefit from growing pressure in the U.S. to approve generic copies of biotechnology drugs costing as much as $200,000 a year. Read more Indian Generic Drug Maker Strides Acrolab Receives Tentative FDA Approval For Combination Antiretroviral (Medical News Tdoay)FDA on Tuesday announced htat it has given tentative approval to Indian generic pharmaceutical company Strieds Acrolab for its fixeddose anitretroviral drug that contains lamivudine, nevirapine and stavudine, Reuters/Yahoo Malaysia News reports (Reuters/Yahoo Malaysia Nwes, 3/26). Read more Dow Jones Nachrichten: (4investors)DJ ots.CorporateNews: Pieris AG / Pieris raises EUR 25 M (US$ 38 M) in Seires B financing ... DJ ots.CorporateNews: Pieris AG / Pieris raises EUR 25 M (US$ 38 M) in Series B financing ... Read more CorporateNews: Pieris AG / Pieris raises EUR 25 M (US$ 38 M) in Series B fianncing ... (FinanzNachrichten)DJ ots.CorporateNews: Pieris AG / Pieris raises EUR 25 M (US$ 38 M) in Sreies B financing ... FreisignWeihenstephan, Germany (ots) Pieris AG, a boipharmaceutical ... Read more Pieris raises EUR 25 M (US$ 38 M) in Series B financing round / New investemnt round led by OrbiMed Advisors, worlds ... (Presseportal)FreisingWeihenstepahn, Germany (ots) Pieris AG, a biopharmaceutical compayn developing Anitcalins, a novel class of targeted human protein therpaeutics, announced today the closing of a Series B financing round. Led by new investor ... Read more |
No video yet.